Construction and in vivo/in vitro evaluation of a nanoporous ion-responsive targeted drug delivery system for recombinant human interferon α-2b delivery

References

• Pagán Carrasco S, Arranz Maestro D. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia. Archivos De La Sociedad Española De Oftalmología (English Edition). 2017;92(9):442–446. doi:10.1016/j.oftale.2017.03.019
   Google Scholar
• Zhang N, Liu ZW, Han QY, Chen J, Lv Y. Xanthohumol enhances antiviral effect of interferon α-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus. Phytomedicine. 2010;17(5):310–316. doi:10.1016/j.phymed.2009.08.00519748253
   PubMedGoogle Scholar
• Coulombe F, Jaworska J, Verway M, et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity. 2014;40(4):554–568. doi:10.1016/j.immuni.2014.02.01324726877
   PubMed Web of Science ®Google Scholar
• Hong WS, Jett JR, Sasaki Y, et al. Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines. Jpn J Clin Oncol. 1987;17(1):49–55.2435930
   PubMed Web of Science ®Google Scholar
• Xu J, Tan L, Goodrum KJ, Kieliszewski MJ. High-yields and extended serum half-life of human interferon alpha2b expressed in tobacco cells as arabinogalactan-protein fusions. Biotechnol Bioeng. 2010;97(5):997–1008. doi:10.1002/(ISSN)1097-0290
   Google Scholar
• Yang L, Yang W, Bi D, ZENG Q. A novel method to prepare highly encapsulated interferon-α-2b containing liposomes for intramuscular sustained release. Eur J Pharm Biopharm. 2006;64(1):0–15. doi:10.1016/j.ejpb.2006.03.003
   Web of Science ®Google Scholar
• Gu JF. Application of ion-exchange resin drug carrier in drug delivery system. Ion Exch Adsorpt. 2010;26(1):89–96.
   Google Scholar
• Liu HF, Su XY, Li X, et al. Development of prolonged release microspheres of metformin hydrochloride using ion exchange resins. J Chin Pharm Sci. 2006;15(3):155–161.
   Google Scholar
• Liu HF, Zhang S, Nie S, et al. Preparation and characterization of a novel pH-sensitive ion exchange resin. Chem Pharm Bull. 2005;53(6):631–633.15930772
   PubMed Web of Science ®Google Scholar
• Gull I, Samra ZQ, Aslam MS, Athar MA. Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b. Springerplus. 2013;2(1):264. doi:10.1186/2193-1801-2-26423875128
   PubMedGoogle Scholar
• Liang X, Wang H, Tian H, LUO H, CHANG J. Synthesis, structure and properties of novel quaternized carboxymethyl chitosan with drug loading capacity. Acta Physico-Chimica Sinica. 2008;24(2):223–229. doi:10.1016/S1872-1508(08)60011-X
   Web of Science ®Google Scholar
• Wang J, Chen JS, Zong JY, et al. Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery. J Phys Chem C. 2010;114(44):18940–18945. doi:10.1021/jp105906p
   Web of Science ®Google Scholar
• Luo Y, Teng Z, Wang Q. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem. 2012;60(3):836–843. doi:10.1021/jf204194z22224939
   PubMed Web of Science ®Google Scholar
• Mattioli-Belmonte DM, Gigante A, Muzzarelli RAA, et al. N,N-dicarboxymethyl chitosan as delivery agent for bone morphogenetic protein in the repair of articular cartilage. Med Biol Eng Comput. 1999;37(1):130. doi:10.1007/BF0251327910396855
   PubMedGoogle Scholar
• Budiraharjo R, Neoh KG, Kang ET. Hydroxyapatite-coated carboxymethyl chitosan scaffolds for promoting osteoblast and stem cell differentiation. J Colloid Interface Sci. 2012;366(1):224–232. doi:10.1016/j.jcis.2011.09.07222024371
   PubMed Web of Science ®Google Scholar
• Chen XG, Wang Z, Liu WS, Park H-J. The effect of carboxymethyl-chitosan on proliferation and collagen secretion of normal and keloid skin fibroblasts. Biomaterials. 2002;23(23):4609–4614.12322982
   PubMed Web of Science ®Google Scholar
• Hiroki A, Tran HT, Nagasawa N, Yagi T, Tamada M. Metal adsorption of carboxymethyl cellulose/carboxymethyl chitosan blend hydrogels prepared by Gamma irradiation. Radiat Phys Chem. 2009;78(12):1076–1080. doi:10.1016/j.radphyschem.2009.05.003
   Web of Science ®Google Scholar
• Guo BL, Gao QY. Preparation and properties of a pH/temperature-responsive carboxymethyl chitosan/poly(N-isopropylacrylamide) semi-IPN hydrogel for oral delivery of drugs. Carbohydr Res. 2007;342(16):2416–2422. doi:10.1016/j.carres.2007.07.00717669378
   PubMed Web of Science ®Google Scholar
• Yang C, Xu L, Zhou Y, et al. A green fabrication approach of gelatin/CM-chitosan hybrid hydrogel for wound healing. Carbohydr Polym. 2010;82(4):1297–1305. doi:10.1016/j.carbpol.2010.07.013
   Web of Science ®Google Scholar
• Hu L, Sun Y, Wu Y. Advances in chitosan-based drug delivery vehicles. Nanoscale. 2013;5(8):3103–3111. doi:10.1039/c3nr00338h23515527
   PubMedGoogle Scholar
• Gujarathi NA, Rane BR, Patel JK. PH sensitive polyelectrolyte complex of O-carboxymethyl chitosan and poly (acrylic acid) cross-linked with calcium for sustained delivery of acid susceptible drugs. Int J Pharm. 2012;436(1–2):418–425. doi:10.1016/j.ijpharm.2012.07.01622814224
   PubMedGoogle Scholar
• Feng C, Wang Z, Jiang C, et al. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Int J Pharm. 2013;457(1):158–167. doi:10.1016/j.ijpharm.2013.07.07924029170
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao D, Wang JT. Preparation of o-carboxymethyl chitosan by schiff base and antibacterial activity. Adv Mater Res. 2013;647:794–797. doi:10.4028/www.scientific.net/AMR.647.794
   Google Scholar
• Narayanan D, Ninan N, Jayakumar R, et al. O-carboxymethyl chitosan nanoparticles for controlled release of non-steroidal anti-inflammatory drugs. Adv Sci. 2014;6(5):522–530(9).
   Google Scholar
• Mccarthy JD, Agnone J, Johnson EW. Preparation and characterization of o-carboxymethyl chitosan ion-complexed poly(l-lysine) for drug and gene delivery system. J Korean Ind Eng Chem. 2010;21(6):2267–2292.
   Google Scholar
• Liu Z, Jiao Y, Zhang Z. Calcium-carboxymethyl chitosan hydrogel beads for protein drug delivery system. J Appl Polym Sci. 2007;103(5):3164–3168. doi:10.1002/(ISSN)1097-4628
   Web of Science ®Google Scholar
• Lu G, Sheng B, Wei Y, et al. Collagen nanofiber-covered porous biodegradable carboxymethyl chitosan microcarriers for tissue engineering cartilage. Eur Polym J. 2008;44(9):2820–2829. doi:10.1016/j.eurpolymj.2008.06.021
   Web of Science ®Google Scholar
• Raghunathan Y, Amsel L, Hinsvark O, Bryant W. Sustained-release drug delivery system I: coated ion-exchange resin system for phenylpropanolamine and other drugs. J Pharm Sci. 2010;70(4):379–384. doi:10.1002/jps.2600700409
   Google Scholar
• Chen M. Electrostatic self-assembly of multilayer copolymeric membranes on the surface of porous tantalum implants for sustained release of doxorubicin. Int J Nanomed. 2011;6:3057–3064. doi:10.2147/IJN.S25918
   PubMed Web of Science ®Google Scholar
• Mendes AC, Strohmenger T, Goycoolea F, Chronakis IS. Electrostatic self-assembly of polysaccharides into nanofibers. Colloids Surf A. 2017;531:182–188. doi:10.1016/j.colsurfa.2017.07.044
   Google Scholar
• Fu J, Zhang M, Liu L, Xiao L, Li M, Ao Y. Layer-by-Layer electrostatic self-assembly silica/graphene oxide onto carbon fiber surface for enhance interfacial strength of epoxy composites. Mater Lett. 2018;236:69–72. doi:10.1016/j.matlet.2018.10.077
   Web of Science ®Google Scholar
• Ai H, Jones SA, Villiers MMD, Lvov YM. Nano-encapsulation of furosemide microcrystals for controlled drug release. J Controlled Release. 2003;86(1):59–68. doi:10.1016/S0168-3659(02)00322-X
   PubMed Web of Science ®Google Scholar
• Li B, Zhen XC, Chen LB, et al. Preparation and characterization of porous chitosan microspheres. J Nanjing Univ. 2010;46(2):186–191.
   Google Scholar
• Li X, Yuan H, Zhang C, et al. Preparation and in‐vitro/in‐vivo evaluation of curcumin nanosuspension with solubility enhancement. J Pharm Pharmacol. 2016;68(8):980–988. doi:10.1111/jphp.1257527283220
   PubMed Web of Science ®Google Scholar
• Shi XC, Rao CM, Pei DN, et al. Studies on circular dichroism (CD) spectra of recombinant human interferon alpha 2a. Chin J Pharm Anal. 2005;25(10):1169–1172.
   Google Scholar
• Nigro E, Stiuso P, Matera MG, et al. The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement. Pulm Pharmacol Ther. 2019;55:25–30. doi:10.1016/j.pupt.2019.01.00430654148
   PubMed Web of Science ®Google Scholar
• Milligan G, Alvarezcurto E, Watterson KR, et al. Short-chain fatty acids increase expression and secretion of stromal cell-derived factor-1 in mouse and human pre-adipocytes. Hormones. 2014;13(4):532–542. doi:10.14310/horm.2002.151925402374
   PubMedGoogle Scholar
• Zhou Q, Gui S, Zhou Q, Wang Y, Samant R. Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway. PLoS One. 2014;9(7):e101132. doi:10.1371/journal.pone.010113224992189
   PubMedGoogle Scholar
• Grela E, Kozłowska J, Grabowiecka A. Current methodology of MTT assay in bacteria – A review. Acta Histochem. 2018;120(4):303–311. doi:10.1016/j.acthis.2018.03.00729606555
   PubMed Web of Science ®Google Scholar
• Zhang X, Xia J, Zhang W, Luo Y, Sun W, Zhou W. Study on pharmacokinetics and tissue distribution of single dose oral tryptanthrin in Kunming mice by validated reversed-phase high-performance liquid chromatography with ultraviolet detection. Integr Med Res. 2017;6(3):269–279. doi:10.1016/j.imr.2017.05.00128951841
   PubMed Web of Science ®Google Scholar
• Shukla DJ, Vyas HA, Vyas MK, Ashok BK, Ravishankar B. A comparative study on chronic administration of Go Ghrita (cow ghee) and Avika Ghrita (ewe ghee) in albino rats. Ayu. 2012;33(3):435. doi:10.4103/0974-8520.10886223723655
   PubMedGoogle Scholar
• Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH. Drug-dependent clearance of human platelets in the NOD/SCID mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood. 2010;116(16):3033–3038. doi:10.1182/blood-2010-03-27776420587782
   PubMedGoogle Scholar
• Van Herck H, Baumans V, Brandt C, et al. Blood sampling from the retro-orbital plexus, the saphenous vein and the tail vein in rats: comparative effects on selected behavioral and blood variables. Lab Anim. 2001;35(2):131–139. doi:10.1258/002367701191149911315161
   PubMedGoogle Scholar
• Lequin RM. Enzyme Immunoassay (EIA)/Enzyme-Linked Immunosorbent Assay (ELISA). Clin Chem. 2005;51(12):2415–2418. doi:10.1373/clinchem.2005.05153216179424
   PubMed Web of Science ®Google Scholar
• Lu L, Lu Y, Zou H, et al. Pharmacokinetics Study of Intereron α-2b PLGA Microspheres in Rats by ELISA. Chin Pharm J 2008;23.
   Google Scholar
• Kutscher HL, Chao P, Deshmukh M, et al. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J Controlled Release. 2010;143(1):31–37. doi:10.1016/j.jconrel.2009.12.019
   PubMed Web of Science ®Google Scholar
• Chen Z, Luo YY, Guo ZF. CA-gel/PLGA composite microspheres loaded protein by SPG membrane emulsification. Acta Scientiarum Naturalium Universitatis Sunyatseni. 2016;55(5):96–102. doi:10.13471/j.cnki.acta.snus.2016.05.017
   Google Scholar
• Varma S, Sadasivan C. A long acting biodegradable-controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen. Biomed Pharmacother. 2014;68(2):225–230. doi:10.1016/j.biopha.2013.08.00924051124
   PubMedGoogle Scholar
• Kaur K, Kush P, Pandey RS, Madan J, Jain UK, Katare OP. Stealth lipid coated aquasomes bearing recombinant human interferon-α-2b offered prolonged release and enhanced cytotoxicity in ovarian cancer cells. Biomed Pharmacother. 2015;69:267–276. doi:10.1016/j.biopha.2014.12.00725661369
   PubMedGoogle Scholar
• Hermeling S, Schellekens H, Maas C, et al. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation. J Pharm Sci. 2010;95(5):1084–1096. doi:10.1002/jps.20599
   Google Scholar
• Martyre MC, Beaupain R, Falcoff E. Potentiation of antiproliferative activity by mixtures of human recombinant IFN-α2 and−γ on growth of human cancer nodules maintained in continuous organotypic culture. Eur J Cancer Clin Oncol. 1987;23(7):917–922.3117562
   PubMedGoogle Scholar
• Ezzat HM, Elnaggar YSR, Abdallah OY. Improved oral bioavailability of the anticancer drug catechin using chitosomes: design, in-vitro appraisal and in-vivo studies. Int J Pharm. 2019. doi:10.1016/j.ijpharm.2019.05.034
   PubMedGoogle Scholar
• Yang F, Shu Y, Yang Y, et al. The pharmacokinetics of recombinant human interferon-alpha-2b poly (lactic-co-glycolic acid) microspheres in rats. J Microencapsulation. 2011;28(6):483–489. doi:10.3109/02652048.2011.58606521718088
   PubMed Web of Science ®Google Scholar
• Yang L, Yang W, Bi D, Zeng Q. A novel method to prepare highly encapsulated interferon-α-2b containing liposomes for intramuscular sustained release. Eur J Pharm Biopharm. 2006;64(1):9–15. doi:10.1016/j.ejpb.2006.03.00316797953
   PubMedGoogle Scholar